These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12086486)

  • 81. Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642.
    Martin J; Sarai K; Yoshitake M; Haberstroh J; Takahashi N; Lutter G; Beyersdorf F
    Eur J Cardiothorac Surg; 1998 Dec; 14(6):607-14. PubMed ID: 9879873
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion.
    Scholz W; Albus U; Counillon L; Gögelein H; Lang HJ; Linz W; Weichert A; Schölkens BA
    Cardiovasc Res; 1995 Feb; 29(2):260-8. PubMed ID: 7736504
    [TBL] [Abstract][Full Text] [Related]  

  • 83. New Na(+)-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart.
    Hendrikx M; Mubagwa K; Verdonck F; Overloop K; Van Hecke P; Vanstapel F; Van Lommel A; Verbeken E; Lauweryns J; Flameng W
    Circulation; 1994 Jun; 89(6):2787-98. PubMed ID: 8205693
    [TBL] [Abstract][Full Text] [Related]  

  • 84. TY-12533, a novel Na(+)/H(+) exchange inhibitor, prevents myocardial stunning in dogs.
    Aihara K; Hisa H; Sasamori J; Yoneyama F; Yamaguchi F; Satoh I; Satoh S
    Eur J Pharmacol; 2001 May; 419(1):93-7. PubMed ID: 11348635
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents.
    Chen H; Li G; Zhan P; Liu X
    Eur J Med Chem; 2011 Nov; 46(11):5609-15. PubMed ID: 21993151
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prediction of inhibition of the sodium ion-proton antiporter by benzoylguanidine derivatives from molecular structure.
    Kauffman GW; Jurs PC
    J Chem Inf Comput Sci; 2000; 40(3):753-61. PubMed ID: 10850779
    [TBL] [Abstract][Full Text] [Related]  

  • 87. New concept for treatment of acute myocardial ischemia.
    Conti CR
    Clin Cardiol; 1998 Apr; 21(4):234. PubMed ID: 9562931
    [No Abstract]   [Full Text] [Related]  

  • 88. Ni
    Vassilyeva OY; Buvaylo EA; Kokozay VN; Studzinsky SL; Skelton BW; Vasyliev GS
    Acta Crystallogr E Crystallogr Commun; 2022 Jan; 78(Pt 2):173-178. PubMed ID: 35145746
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Tuneable access to indole, indolone, and cinnoline derivatives from a common 1,4-diketone Michael acceptor.
    El-Marrouki D; Touchet S; Abdelli A; M'Rabet H; Lotfi Efrit M; Gros PC
    Beilstein J Org Chem; 2020; 16():1722-1731. PubMed ID: 32733616
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Role of pHi, and proton transporters in oncogene-driven neoplastic transformation.
    Reshkin SJ; Greco MR; Cardone RA
    Philos Trans R Soc Lond B Biol Sci; 2014 Mar; 369(1638):20130100. PubMed ID: 24493748
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research.
    Harguindey S; Arranz JL; Polo Orozco JD; Rauch C; Fais S; Cardone RA; Reshkin SJ
    J Transl Med; 2013 Nov; 11():282. PubMed ID: 24195657
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M
    Am J Cardiol; 1999 May; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel, non-acylguanidine-type Na(+)/H(+) exchanger inhibitors: synthesis and pharmacology of 5-tetrahydroquinolinylidene aminoguanidine derivatives.
    Fukumoto S; Imamiya E; Kusumoto K; Fujiwara S; Watanabe T; Shiraishi M
    J Med Chem; 2002 Jul; 45(14):3009-21. PubMed ID: 12086486
    [TBL] [Abstract][Full Text] [Related]  

  • 94. In vitro and in vivo pharmacology of a structurally novel Na+-H+ exchange inhibitor, T-162559.
    Kusumoto K; Igata H; Abe A; Ikeda S; Tsuboi A; Imamiya E; Fukumoto S; Shiraishi M; Watanabe T
    Br J Pharmacol; 2002 Apr; 135(8):1995-2003. PubMed ID: 11959803
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Potent and selective inhibition of the human Na+/H+ exchanger isoform NHE1 by a novel aminoguanidine derivative T-162559.
    Kawamoto T; Kimura H; Kusumoto K; Fukumoto S; Shiraishi M; Watanabe T; Sawada H
    Eur J Pharmacol; 2001 May; 420(1):1-8. PubMed ID: 11412833
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Synthesis and Na(+)/H(+) exchanger-1 inhibitory activity of substituted (quinolinecarbonyl)guanidine derivatives.
    Mao D; Xu Y; Hu X; Zhang G; Dong J; Gong G
    Chem Biodivers; 2009 Oct; 6(10):1727-36. PubMed ID: 19842138
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.